SIRT1 and Cognitive impairment: SIRT1 serum reduction was shown in Alzheimer’s disease and mild cognitive impairment (33), obesity (34) and lung diseases (35), suggesting that serum SIRT1 may be a potential biomarker for various aging-associated diseases.